What does Mymetics Corporation do?

Mymetics Corporation (MYMX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is MYMX's market cap?

Mymetics Corporation (MYMX) has a market capitalization of approximately $46, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does MYMX pay a dividend?

No — Mymetics Corporation (MYMX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Mymetics Corporation (MYMX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

MYMX

Mymetics Corporation

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$46.00·Market closed·Aug 26 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−100.00%CAGR −92.68%

Select date range

FromTo

Feb 9, 1995Aug 28, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

MYMX does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 15

Last Report DateNov 20

Reported vs Estimate−$0.00

Earnings Surprise—

FinancialsFinancials Tab

Revenue€359.66K

Net Income−€11.57M

Net Margin−3,216.1%

Operating Cash Flow−€1.74M

Capital Expenditures€34.97

Free Cash Flow−€1.74M

Return on Equity—

Return on Invested Capital83.0%

Net Debt€75.05M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for MYMX and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how MYMX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MYMX and 80,000+ other tickers.

About Mymetics Corporation

Mymetics Corporation is a Swiss biotechnology company dedicated to the research and development of vaccines aimed at preventing infectious and debilitating diseases. Its robust pipeline features several promising vaccine candidates, including those for HIV-1/AIDS, COVID-19, intranasal influenza, respiratory syncytial virus (RSV), malaria, and chikungunya. The company actively collaborates with leading institutions such as the Texas Biomedical Research Institute, the PATH Malaria Vaccine Initiative, and the National Institute of Allergy and Infectious Diseases' Laboratory of Malaria Immunology…

CEO: Ronald Kempers
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 2
Website: www.mymetics.com

Peers

Cannabiz Mobile, Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About MYMX

What does Mymetics Corporation do?: Mymetics Corporation (MYMX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is MYMX's market cap?: Mymetics Corporation (MYMX) has a market capitalization of approximately $46, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does MYMX pay a dividend?: No — Mymetics Corporation (MYMX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is MYMX profitable?: Mymetics Corporation (MYMX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.